Budesonide formoterol

Results: 146



#Item
71Asthma & the Over 65s An information paper for health professionals  for HEALTH PROFESSIONALS

Asthma & the Over 65s An information paper for health professionals for HEALTH PROFESSIONALS

Add to Reading List

Source URL: www.nationalasthma.org.au

Language: English - Date: 2013-05-09 01:30:49
72ARTICLES  Age and Risks of FDA–Approved Long-Acting ␤2-Adrenergic Receptor Agonists AUTHORS: Ann W. McMahon, MD, MS,a Mark S. Levenson, PhD,b Bradley W. McEvoy, DrPH,b Andrew D. Mosholder,

ARTICLES Age and Risks of FDA–Approved Long-Acting ␤2-Adrenergic Receptor Agonists AUTHORS: Ann W. McMahon, MD, MS,a Mark S. Levenson, PhD,b Bradley W. McEvoy, DrPH,b Andrew D. Mosholder,

Add to Reading List

Source URL: pediatrics.aappublications.org

Language: English
73US Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee Meeting April 17, 2013 Susan Limb, MD Clinical Team Leader

US Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee Meeting April 17, 2013 Susan Limb, MD Clinical Team Leader

Add to Reading List

Source URL: www.fda.gov

Language: English
74U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

Add to Reading List

Source URL: www.fda.gov

Language: English
75English 2008 Astham DUE bulletin v2.qxp

English 2008 Astham DUE bulletin v2.qxp

Add to Reading List

Source URL: www.csfs.org

Language: English - Date: 2011-06-28 15:33:04
76US Food and Drug Administration.  Pulmonary-Allergy Drugs  Advisory Committee Meeting September 10, 2013

US Food and Drug Administration. Pulmonary-Allergy Drugs Advisory Committee Meeting September 10, 2013

Add to Reading List

Source URL: www.fda.gov

Language: English
77Kansas Drug Utilization Review Newsletter Published by Health Information Designs, Inc. Spring 2010 Welcome to the spring 2010 edition of the “Kansas Drug Utilization Review Newsletter,” published by Health Informati

Kansas Drug Utilization Review Newsletter Published by Health Information Designs, Inc. Spring 2010 Welcome to the spring 2010 edition of the “Kansas Drug Utilization Review Newsletter,” published by Health Informati

Add to Reading List

Source URL: www.kdheks.gov

Language: English - Date: 2012-02-06 11:13:40
78PULMONARY ALLERGY DRUGS ADVISORY COMMITTEE MEETING FDA Briefing Document March 7, 2013

PULMONARY ALLERGY DRUGS ADVISORY COMMITTEE MEETING FDA Briefing Document March 7, 2013

Add to Reading List

Source URL: www.fda.gov

Language: English
79U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

Add to Reading List

Source URL: www.fda.gov

Language: English
80AAFA 321 hor_MAC_ [Converted]

AAFA 321 hor_MAC_ [Converted]

Add to Reading List

Source URL: www.timeincnewsgroupcustompub.com

Language: English - Date: 2014-06-17 11:28:36